#weight-loss-drugs

[ follow ]
#obesity-treatment

High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs-but it can be critical for retaining talent

Employers are increasingly offering health benefits for weight loss drugs, impacting healthcare costs amidst high demand and rising obesity rates.

Top doctor alarmed by weight-loss drug misuse

NHS warns against the inappropriate use of weight-loss drugs without medical supervision.

Which Weight Loss Drug Should You Choose (if You Get to Choose)?

People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Oprah Takes on Weight Stigma in the Ozempic Era

Weight loss drugs shift stigma around obesity and shame associated with dieting.
Patients feel shamed for using weight loss drugs, highlighting internal and external biases.

High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs-but it can be critical for retaining talent

Employers are increasingly offering health benefits for weight loss drugs, impacting healthcare costs amidst high demand and rising obesity rates.

Top doctor alarmed by weight-loss drug misuse

NHS warns against the inappropriate use of weight-loss drugs without medical supervision.

Which Weight Loss Drug Should You Choose (if You Get to Choose)?

People with obesity now have a choice between semaglutide and tirzepatide for weight loss, but deciding which to take is complex.

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Oprah Takes on Weight Stigma in the Ozempic Era

Weight loss drugs shift stigma around obesity and shame associated with dieting.
Patients feel shamed for using weight loss drugs, highlighting internal and external biases.
moreobesity-treatment
#ozempic

Drugmakers and pharmacists battle over who gets to make obesity drugs

Demand for Ozempic and its alternatives has led to compounded versions, but brand manufacturers are actively trying to eliminate this competition.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

How little Denmark got homegrown giant Novo Nordisk to lower Ozempic prices

Pharmaceutical pricing conflicts raise challenges globally, as Denmark struggles to afford Novo Nordisk's drugs despite their local production.

Insider Today: Austin's genius housing fix

The soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

Ozempic, originally a diabetes treatment, has become a major weight loss drug, generating $14 billion in 2023 sales for Novo Nordisk.

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

Ozempic's weight loss success surprisingly boosts Novo Nordisk's profits, transforming it into a pharmaceutical giant amid regulatory scrutiny and high sales.
Despite scandals and lawsuits, Novo Nordisk's future stock performance remains a primary concern for investors.

Drugmakers and pharmacists battle over who gets to make obesity drugs

Demand for Ozempic and its alternatives has led to compounded versions, but brand manufacturers are actively trying to eliminate this competition.

The Future of Ozempic Is Coming Into Focus

The rising popularity of Ozempic alternatives continues despite expected supply increases due to significant pricing differences.

How little Denmark got homegrown giant Novo Nordisk to lower Ozempic prices

Pharmaceutical pricing conflicts raise challenges globally, as Denmark struggles to afford Novo Nordisk's drugs despite their local production.

Insider Today: Austin's genius housing fix

The soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

Ozempic, originally a diabetes treatment, has become a major weight loss drug, generating $14 billion in 2023 sales for Novo Nordisk.

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

Ozempic's weight loss success surprisingly boosts Novo Nordisk's profits, transforming it into a pharmaceutical giant amid regulatory scrutiny and high sales.
Despite scandals and lawsuits, Novo Nordisk's future stock performance remains a primary concern for investors.
moreozempic

Medicaid dominates coverage of Novo, Lilly weight-loss drugs

Government health plans overwhelmingly dominate coverage for weight-loss drugs, covering over 52 million Americans compared to about 24 million in private plans.
#eli-lilly

Unemployed to be given weight-loss jab to help them back into work, government says

Eli Lilly invests £279 million in UK's life sciences for weight-loss jab trials aimed at reducing unemployment and health burdens.

Lilly sells Zepbound vials at 50% discount to meet weight loss drug demand

Eli Lilly launches Zepbound vials at lower prices to address supply shortages and boost access for patients.

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Eli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.

Eli Lilly just made its weight-loss drug cheaper with a simple design tweak

Eli Lilly's new Zepbound vials improve drug access and affordability despite increased user difficulty compared to autoinjector pens.

Could weight loss drugs fix UK's unemployment problem?

Eli Lilly is testing weight-loss drugs in the UK to see if they can help reduce unemployment rates by getting people back to work.

Has Eli Lilly Destroyed Hims & Hers Upside?

Hims & Hers Health capitalized on weight-loss drug market trends while facing new competition from Eli Lilly's FDA-approved product offerings.

Unemployed to be given weight-loss jab to help them back into work, government says

Eli Lilly invests £279 million in UK's life sciences for weight-loss jab trials aimed at reducing unemployment and health burdens.

Lilly sells Zepbound vials at 50% discount to meet weight loss drug demand

Eli Lilly launches Zepbound vials at lower prices to address supply shortages and boost access for patients.

Eli Lilly just halved the price of its weight-loss drug - declaring war on the booming market of knock-offs

Eli Lilly is significantly reducing the price of Zepbound to $399-$549 to combat counterfeits and enhance patient access.

Eli Lilly just made its weight-loss drug cheaper with a simple design tweak

Eli Lilly's new Zepbound vials improve drug access and affordability despite increased user difficulty compared to autoinjector pens.

Could weight loss drugs fix UK's unemployment problem?

Eli Lilly is testing weight-loss drugs in the UK to see if they can help reduce unemployment rates by getting people back to work.

Has Eli Lilly Destroyed Hims & Hers Upside?

Hims & Hers Health capitalized on weight-loss drug market trends while facing new competition from Eli Lilly's FDA-approved product offerings.
moreeli-lilly
#fashion-industry

Vogue boss 'concerned' by return to skinny models

The fashion industry is shifting back to favoring skinny models, raising concerns about body diversity and the influence of weight-loss drugs like Ozempic.

Ozempic is killing fashion's body inclusivity movement

The size inclusivity movement in fashion has seen a decline in recent years despite progress made earlier.
The rise in popularity of weight-loss drugs like Ozempic and Wegovy may have played a role in this decline.

Vogue boss 'concerned' by return to skinny models

The fashion industry is shifting back to favoring skinny models, raising concerns about body diversity and the influence of weight-loss drugs like Ozempic.

Ozempic is killing fashion's body inclusivity movement

The size inclusivity movement in fashion has seen a decline in recent years despite progress made earlier.
The rise in popularity of weight-loss drugs like Ozempic and Wegovy may have played a role in this decline.
morefashion-industry
#pharmaceutical-industry

Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed

Chinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.

Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market

Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.

Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed

Chinese and Indian pharmaceutical companies are developing cheaper weight-loss drug versions to reach more people globally.

Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market

Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.

Drugmaker shut down after black schmutz found in injectable weight-loss drug

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
morepharmaceutical-industry
#obesity

Using Ozempic to get beach body ready' risks dangerous complications NHS chief

Weight-loss drugs like Ozempic and Wegovy should only be used under strict medical supervision for severe obesity or health issues, not for quick fixes or beach body goals.

Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled

Teenagers are increasingly being prescribed semaglutide drugs, raising concerns about long-term health impacts.

How will weight-loss drugs change our relationship with food?

Weight-loss drugs are reshaping the conversation around obesity, challenging moral stigmas and impacting societal attitudes toward health and personal responsibility.

How blockbuster obesity drugs create a full feeling - even before one bite of food

Scientists have identified two distinct groups of neurons in the brain associated with pre-meal fullness and post-meal satiety.

Should young kids take the new anti-obesity drugs? What the research says

The use of obesity drugs like GLP-1 mimics in children could address significant health issues related to obesity.

Health and productivity losses from obesity far outstrip weight-loss jab costs'

Healthcare costs from obesity surpass the expense of new weight-loss drugs, showing economic benefits for their use.

Using Ozempic to get beach body ready' risks dangerous complications NHS chief

Weight-loss drugs like Ozempic and Wegovy should only be used under strict medical supervision for severe obesity or health issues, not for quick fixes or beach body goals.

Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled

Teenagers are increasingly being prescribed semaglutide drugs, raising concerns about long-term health impacts.

How will weight-loss drugs change our relationship with food?

Weight-loss drugs are reshaping the conversation around obesity, challenging moral stigmas and impacting societal attitudes toward health and personal responsibility.

How blockbuster obesity drugs create a full feeling - even before one bite of food

Scientists have identified two distinct groups of neurons in the brain associated with pre-meal fullness and post-meal satiety.

Should young kids take the new anti-obesity drugs? What the research says

The use of obesity drugs like GLP-1 mimics in children could address significant health issues related to obesity.

Health and productivity losses from obesity far outstrip weight-loss jab costs'

Healthcare costs from obesity surpass the expense of new weight-loss drugs, showing economic benefits for their use.
moreobesity

Ozempic may help battle drug and alcohol addiction

Weight-loss drugs Ozempic and Mounjaro may help reduce substance abuse cravings and binging, showing protective effects on overdose and binge drinking rates.
#novo-nordisk

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk's decision to halt production of insulin pens raises ethical concerns over prioritizing profits from weight-loss drugs over patients' health.

Wegovy Approved to Cut Heart Disease and Stroke Risk

Weight loss drugs approved for heart health benefits
Semaglutide linked to cardiovascular risk reduction

Novo Nordisk's record-breaking growth highlights 'insatiable demand' for weight loss drugs

Novo Nordisk achieved a 20-year high in revenue growth rate, beating estimates for FY2023 revenue and earnings.
The growth is not demand constrained but production capacity constrained, with an insatiable demand for weight loss drugs.

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk's decision to halt production of insulin pens raises ethical concerns over prioritizing profits from weight-loss drugs over patients' health.

Wegovy Approved to Cut Heart Disease and Stroke Risk

Weight loss drugs approved for heart health benefits
Semaglutide linked to cardiovascular risk reduction

Novo Nordisk's record-breaking growth highlights 'insatiable demand' for weight loss drugs

Novo Nordisk achieved a 20-year high in revenue growth rate, beating estimates for FY2023 revenue and earnings.
The growth is not demand constrained but production capacity constrained, with an insatiable demand for weight loss drugs.
morenovo-nordisk

'Fake weight loss drug nearly killed me'

Be cautious about purchasing weight loss drugs online; they may not be safe or legitimate.
#semaglutide

The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear

Consumers overdosing on knock-off semaglutide weight-loss drugs.

Ozempic may help manage opioid addiction: study

Semaglutide (Ozempic) significantly reduces the likelihood of opioid overdoses in patients with a history of opioid abuse, offering potential in addiction management.

Weight-loss drugs slow down the ageing process', scientists suggest

Weight-loss drugs like semaglutide may significantly enhance longevity and health by reducing overall mortality rates.

A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs

Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain.

The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear

Consumers overdosing on knock-off semaglutide weight-loss drugs.

Ozempic may help manage opioid addiction: study

Semaglutide (Ozempic) significantly reduces the likelihood of opioid overdoses in patients with a history of opioid abuse, offering potential in addiction management.

Weight-loss drugs slow down the ageing process', scientists suggest

Weight-loss drugs like semaglutide may significantly enhance longevity and health by reducing overall mortality rates.

A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs

Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain.
moresemaglutide

New Weight Loss Drug Has Small Problem: Uncontrollable Vomiting

Roche's weight loss drug CT-388 shows high vomiting rates in trials, raising concerns for investors.

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

Nvidia is the leading AI stock, but other companies are outperforming it in 2024.
#glp-1-agonists

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.

Ozempic Gets the Oprah Treatment in a New TV Special

Weight-loss drugs like Ozempic, Wegovy, and Zepbound are becoming increasingly popular.
Oprah Winfrey's support for weight-loss medications in her ABC special may further boost the popularity of these drugs.

Obesity drugs aren't always forever. What happens when you quit?

GLP-1 agonists are popular weight-loss drugs, but many people discontinue due to cost, side effects, and other factors. Stopping these medications can lead to weight regain.

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.

Ozempic Gets the Oprah Treatment in a New TV Special

Weight-loss drugs like Ozempic, Wegovy, and Zepbound are becoming increasingly popular.
Oprah Winfrey's support for weight-loss medications in her ABC special may further boost the popularity of these drugs.

Obesity drugs aren't always forever. What happens when you quit?

GLP-1 agonists are popular weight-loss drugs, but many people discontinue due to cost, side effects, and other factors. Stopping these medications can lead to weight regain.
moreglp-1-agonists
#glp-1

Scientists Are Studying Weight-Loss Drugs for Way More Than Weight Loss

Weight-loss drugs like Wegovy and Zepbound, based on GLP-1, have broader applications beyond weight loss and diabetes.

A scientist tested knock-off Ozempic sold online. He found dangerous ingredients and doses - and got scammed out of money.

The rise in demand for weight-loss drugs has led consumers to purchase potentially dangerous gray market alternatives online.

Scientists Are Studying Weight-Loss Drugs for Way More Than Weight Loss

Weight-loss drugs like Wegovy and Zepbound, based on GLP-1, have broader applications beyond weight loss and diabetes.

A scientist tested knock-off Ozempic sold online. He found dangerous ingredients and doses - and got scammed out of money.

The rise in demand for weight-loss drugs has led consumers to purchase potentially dangerous gray market alternatives online.
moreglp-1
#obesity-care

America's doctors need more obesity medicine training

There is a shortage of healthcare providers trained in obesity care to meet the growing demand for weight-loss drugs.

Weight-loss drug restrictions shine spotlight on imbalance in obesity care

Restrictions on weight-loss drugs raise concerns on coverage imbalance
Employers offer limited coverage for obesity care compared to other conditions

America's doctors need more obesity medicine training

There is a shortage of healthcare providers trained in obesity care to meet the growing demand for weight-loss drugs.

Weight-loss drug restrictions shine spotlight on imbalance in obesity care

Restrictions on weight-loss drugs raise concerns on coverage imbalance
Employers offer limited coverage for obesity care compared to other conditions
moreobesity-care

The next food marketing blitz is aimed at people on new weight-loss drugs

As new weight-loss drugs become popular, food manufacturers are adapting to cater to consumers on these medications.

Hims & Hers to sell inexpensive Ozempic alternative

Online pharmaceutical brands Hims & Hers are introducing a cost-effective weight-loss drug with semaglutide.

"Outrageously" priced weight-loss drugs could bankrupt US health care

The rise of effective weight-loss drugs could significantly impact America's high obesity rate and prescription drug pricing, potentially exerting a massive financial strain on the healthcare system.
#oprah-winfrey

The Ozempic Era Is Distorting What We See as Healthy | The Walrus

Oprah Winfrey explores the societal stigma and the rise of weight loss drugs like Ozempic and Wegovy.

Oprah Says She Is on a Weight Loss Drug and Done With the Shaming'

Oprah Winfrey has revealed that she is taking a medication to manage her weight, sparking discussions around weight management and stigma.
Demand has increased for weight loss drugs like Ozempic, Wegovy, and Zepbound that suppress appetite.

Oprah says she is on a weight loss drug and 'done with the shaming'

Oprah Winfrey has joined the conversation around weight management once again by revealing that she is taking medication to manage her weight.
Demand for weight loss medications has increased, with drugs like Ozempic, Wegovy, and Zepbound being popular choices to suppress appetite.

Opinion | Oprah and America Embrace the Promise of Ozempic

The weight-loss industry is rebranding obesity as a disease, shifting blame from individuals to a medical condition.
Oprah's special focuses on her personal weight-loss journey and the use of drugs like Ozempic, highlighting the industry's shift towards medicalization.

The Ozempic Era Is Distorting What We See as Healthy | The Walrus

Oprah Winfrey explores the societal stigma and the rise of weight loss drugs like Ozempic and Wegovy.

Oprah Says She Is on a Weight Loss Drug and Done With the Shaming'

Oprah Winfrey has revealed that she is taking a medication to manage her weight, sparking discussions around weight management and stigma.
Demand has increased for weight loss drugs like Ozempic, Wegovy, and Zepbound that suppress appetite.

Oprah says she is on a weight loss drug and 'done with the shaming'

Oprah Winfrey has joined the conversation around weight management once again by revealing that she is taking medication to manage her weight.
Demand for weight loss medications has increased, with drugs like Ozempic, Wegovy, and Zepbound being popular choices to suppress appetite.

Opinion | Oprah and America Embrace the Promise of Ozempic

The weight-loss industry is rebranding obesity as a disease, shifting blame from individuals to a medical condition.
Oprah's special focuses on her personal weight-loss journey and the use of drugs like Ozempic, highlighting the industry's shift towards medicalization.
moreoprah-winfrey

Is Ozempic An Antidepressant? Preliminary Studies Suggest It Could Be

Weight loss drugs like Ozempic and Wegovy may have a positive impact on reducing depression and anxiety.
Dulaglutide, a GLP-1 agonist similar to semaglutide, shows potential in reversing metabolic damage in the brain and alleviating depression and anxiety in mice.
#side-effects

Dr. Sanjay Gupta answers your questions about new weight loss drugs

Ozempic, Wegovy, and Mounjaro are weight loss drugs that have potential side effects.
It is important to consult with a healthcare professional before starting or stopping these medications.

Tracking Ozempic's Nausea Side Effect to Specific Neurons May Lead to Better Drugs

Scientists pinpointed a brain pathway involved in nausea from anti-obesity drugs, aiming to develop weight-loss drugs with fewer side effects.

Dr. Sanjay Gupta answers your questions about new weight loss drugs

Ozempic, Wegovy, and Mounjaro are weight loss drugs that have potential side effects.
It is important to consult with a healthcare professional before starting or stopping these medications.

Tracking Ozempic's Nausea Side Effect to Specific Neurons May Lead to Better Drugs

Scientists pinpointed a brain pathway involved in nausea from anti-obesity drugs, aiming to develop weight-loss drugs with fewer side effects.
moreside-effects

Your Body Has Its Own Built-In Ozempic

Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that target regulatory pathways involved in obesity and diabetes.
The body produces natural versions of these drugs, known as incretin hormones, in the gut, and the trillions of gut microbes play a key role in regulating these hormones.

The drug shortages Floridians will face in 2024. Here's what you should know

Drug shortages continue to threaten access to necessary medications, including treatments for short-term and chronic illnesses.
ADHD medications, chemotherapy drugs, weight-loss drugs, and the antibiotic amoxicillin are among the categories experiencing shortages in 2024.

Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro

Pharmaceutical companies have increased prices for over 700 medications, including popular weight-loss drugs.
The average price increase at the start of the year was around 4.5%, slightly slower than previous years.

Weight-loss drug coverage tops unlimited PTO, remote work in benefits survey - The Business Journals

Coverage for weight-loss drugs is a highly desired employee benefit
Employees are willing to change jobs for access to coverage for weight-loss drugs
#glp-1s

Weight-Loss Drugs Don't Cause Suicidal Thoughts, FDA Says

There is no evidence that popular weight-loss drugs cause suicidal thoughts
The FDA's preliminary analysis showed no clear relationship between adverse-event reports of suicidal thoughts and GLP-1s

Weight-loss drugs could become a test case for AI

The convergence of artificial intelligence and weight-loss drugs in healthcare is becoming increasingly prevalent for personalized care and improved patient outcomes.

Weight-Loss Drugs Don't Cause Suicidal Thoughts, FDA Says

There is no evidence that popular weight-loss drugs cause suicidal thoughts
The FDA's preliminary analysis showed no clear relationship between adverse-event reports of suicidal thoughts and GLP-1s

Weight-loss drugs could become a test case for AI

The convergence of artificial intelligence and weight-loss drugs in healthcare is becoming increasingly prevalent for personalized care and improved patient outcomes.
moreglp-1s

Can Dieting Actually Lead to Long-Term Weight Loss?

Weight loss drugs like Wegovy and Zepbound have shown to be more effective than traditional dieting methods.
Short-term dieting can help most people lose a small amount of weight, but long-term success and weight maintenance are challenging.

The Year of Ozempic

Weight-loss drugs may be considered significant advancements in the treatment of chronic disease.
Insulin was a groundbreaking miracle drug in the early 20th century.

What Happens When People Stop Taking the Weight Loss Drug Zepbound

A new study suggests that continuous treatment with weight loss drugs may be necessary to maintain the benefits of weight loss.
Even after stopping the weight loss drug tirzepatide, people did not return to their original weight and continued to show improvements in certain areas.

New Drugs Can Fix Teenage Obesity, but Young People Don't Get Them

Many pediatricians are hesitant to prescribe the weight loss drug Wegovy to children due to concerns about long-term effects.
Obesity in adolescents, especially severe obesity, can lead to serious health complications at a young age.

A New Match for Menopausal Weight Gain: Ozempic

Weight gain during menopause can be a frustrating and challenging experience for women, impacting their self-esteem and overall quality of life.
Some women going through menopause are turning to weight loss drugs like Ozempic to address their weight gain, despite the high costs involved.
Weight loss is recommended as an effective nonhormonal treatment for menopausal symptoms such as hot flashes and night sweats.
#obesity-management

Doctors Surprised When Patients Who Start Semaglutide Are Frequently Cured of Other Conditions

Weight loss drugs like Wegovy and Zepbound may have secondary benefits in improving chronic conditions like arthritis according to medical practitioners.

Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows

Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.

Doctors Surprised When Patients Who Start Semaglutide Are Frequently Cured of Other Conditions

Weight loss drugs like Wegovy and Zepbound may have secondary benefits in improving chronic conditions like arthritis according to medical practitioners.

Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows

Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.
moreobesity-management

Thinking of buying Wegovy online. Here's what to know about compounding pharmacies

Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.

Weight Loss Drugs Are Poised to Cost New York City Retail, According to Study

Weight loss drugs like Ozempic and Wegovy are impacting retail size curves in NYC, leading to potential losses and challenges for brands and retailers.

Nestle and Coke make 'new associations' for consumers using Wegovy and Ozempic

Food companies are adapting to support people taking weight-loss drugs without directly naming medications.

Daily briefing: Cheaper versions of drugs like Wegovy are on their way

Lower-cost versions of weight-loss drugs on the way as patents expire.

Wegovy could attract more male patients, here's why

Men may be hesitant to use weight-loss drugs due to stereotypes and cultural norms, despite potential health benefits.
[ Load more ]